📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Gene modification strategies using AO-mediated exon skipping and CRISPR/Cas9 as potential therapies for Duchenne muscular dystrophy patients. (2020)

First Author: Solberg MH

Attributed to: FUTURE TARGETED HEALTHCARE MANUFACTURING HUB funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1049/enb.2020.0017

PubMed Identifier: 36968157

Publication URI: http://europepmc.org/abstract/MED/36968157

Type: Journal Article/Review

Volume: 4

Parent Publication: Engineering biology

Issue: 3

ISSN: 2398-6182